Literature DB >> 1944889

Mg2+ administered up to twenty-four hours following reperfusion prevents ischemic damage of the Ca1 neurons in the rat hippocampus.

T Tsuda1, K Kogure, K Nishioka, T Watanabe.   

Abstract

Inductively coupled plasma emission spectrometry analysis was applied to determine ischemia-induced changes of Mg2+ and Ca2+ in vulnerable regions of rat brain. This method can provide an accurate quantification and lower detection limits, as compared to atomic absorption spectrophotometry or several other methods. In the hippocampus, Mg2+ content significantly increases 24 h following 20 min of ischemia, followed by a gradual decrease between 48 and 72 h. Ca2+ accumulation was found at 48 and 72 h. At the cell membrane, Mg2+ plays a role as an endogenous calcium channel blocker of both the receptor-operated and voltage-dependent gates and, in the mitochondria, Mg2+ inhibits Ca2+ uptake processes. We propose that the mobilization of Mg2+ after 24 h reperfusion may counteract the process of ischemia-induced neuronal damage and that decreases of Mg2+ may be correlated with the degree of brain injury. However, in the natural concentration of Mg2+, the counteraction may not be sufficient for a neuroprotective effect. Therefore, after 24 h reperfusion, an artificial enhancement of Mg2+ is necessary for neuroprotection. In order to test the above hypothesis, MgCl2, (50 mM) was administered directly to the CA1 sector of the rat hippocampus before and at various intervals following 20 min of ischemia. Pyramidal cells were evaluated seven days later and neuronal density was determined. Consistent with the hypothesis, a neuroprotective effect was observed, even when MgCl2 was administered 24 h, but not 48 h, after the ischemic episode.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1944889     DOI: 10.1016/0306-4522(91)90058-v

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  10 in total

Review 1.  Vitamins and nutrients as primary treatments in experimental brain injury: Clinical implications for nutraceutical therapies.

Authors:  Cole Vonder Haar; Todd C Peterson; Kris M Martens; Michael R Hoane
Journal:  Brain Res       Date:  2015-12-23       Impact factor: 3.252

Review 2.  Magnesium neuroprotection is limited in humans with acute brain injury.

Authors:  J Andrew McKee; Randall P Brewer; Gary E Macy; Cecil O Borel; James D Reynolds; David S Warner
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 3.  Trends in neuroanaesthesia.

Authors:  J E Cottrell
Journal:  Can J Anaesth       Date:  1996-05       Impact factor: 5.063

Review 4.  Magnesium for neuroprotection in ischaemic stroke: rationale for use and evidence of effectiveness.

Authors:  K W Muir
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 5.  Limiting neurological damage after stroke: a review of pharmacological treatment options.

Authors:  S J Read; T Hirano; S M Davis; G A Donnan
Journal:  Drugs Aging       Date:  1999-01       Impact factor: 3.923

6.  Results of the MRI substudy of the intravenous magnesium efficacy in stroke trial.

Authors:  Chelsea S Kidwell; Kennedy R Lees; Keith W Muir; Christopher Chen; Stephen M Davis; Deidre A De Silva; Christopher J Weir; Sidney Starkman; Jeffry R Alger; Jeffrey L Saver
Journal:  Stroke       Date:  2009-03-19       Impact factor: 7.914

7.  A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia.

Authors:  K Valentino; R Newcomb; T Gadbois; T Singh; S Bowersox; S Bitner; A Justice; D Yamashiro; B B Hoffman; R Ciaranello
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

8.  Design of the Intravenous Magnesium Efficacy in Acute Stroke (IMAGES) trial.

Authors:  Andrew Bradford; Kennedy Lees
Journal:  Curr Control Trials Cardiovasc Med       Date:  2000

9.  Combination of therapeutic hypothermia and other neuroprotective strategies after an ischemic cerebral insult.

Authors:  Joline Goossens; Saïd Hachimi-Idrissi
Journal:  Curr Neuropharmacol       Date:  2014-09       Impact factor: 7.363

10.  A Systematic Review of Magnesium Sulfate for Perinatal Neuroprotection: What Have We Learnt From the Past Decade?

Authors:  Robert Galinsky; Justin M Dean; Ingran Lingam; Nicola J Robertson; Carina Mallard; Laura Bennet; Alistair J Gunn
Journal:  Front Neurol       Date:  2020-05-27       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.